Dr Theodora Katsila
LightNews LightNews
banner
theodorakatsila.bsky.social
Dr Theodora Katsila
@theodorakatsila.bsky.social
80 followers 110 following 13 posts
Biochemist. Consultant. Entrepreneur. Research Associate Professor - Biomarker Discovery & Translational Research Lab Head. Craving for brain teasers. http://www.eie.gr/nhrf/institutes/icb/research_groups/KatsilaTheodora_group_en.html
Posts Replies Media Videos
theodorakatsila.bsky.social
Time to share the @katsilalab.bsky.social contribution to IMMUNO-model in Cancer: Methods and Protocols (link.springer.com/book/10.1007...). Chapters 15–17, written together with an exceptional team of scientists and friends within the @immunomodel. This work stands as part of Dr Ouzounis' legacy.
IMMUNO-model in Cancer
This open access volume describes various models that study the responses of the immune system in cancer and test experimental immune-oncology approaches.
link.springer.com
November 7, 2025 at 2:56 PM
theodorakatsila.bsky.social
New paper out 📣 📣 “Towards implantable supercapacitors with high longevity” developed in the framework of #NerveRepack. @katsilalab.bsky.social is proud to contribute to the biocompatibility of next-gen energy materials doi.org/10.1016/j.est.2025.119204#IN3BIOI#biomaterialsl#supercapacitorsrs
https://doi.org/10.1016/j.est.2025.119204
November 6, 2025 at 10:34 AM
theodorakatsila.bsky.social
Today I want to pause and shine a light on a condition that too often goes unseen. To anyone living with #trigeminalneuralgia: you are not alone. Let’s keep raising awareness, supporting research, and talking openly about invisible pain.

ihs-headache.org/en/resources...
Trigeminal Neuralgia Awareness Day - International Headache Society
7 October 7 October is Trigeminal Neuralgia Awareness Day - a day dedicated to supporting those affected by this painful neurological condition. On this
ihs-headache.org
October 7, 2025 at 9:58 PM
theodorakatsila.bsky.social
Reposting with pride!! Big credit to Maria Mina (@katsilalab.bsky.social star), Spyridon-Marios Giatro & Dr Minos Matsoukas. Oct4 "handshakes" via #AlphaFold3. 332 interactors screened; 15 higher-ipTM dimers; 72 confident contacts; phospho states hint alt PPIs. #Bio3_Forum_2025
September 20, 2025 at 4:43 PM
theodorakatsila.bsky.social
Under the Acropolis at the Odeon ✨ @demishassabis on how #AI accelerates #science. Takeaways: progress=open, responsible, collaborative; breakthroughs =data+compute+creativity.
Thanks @KaterinaTzouvara @NikosTzollas. Back to @katsilalab.bsky.social 🚀🚀 @EndeavorGr
September 20, 2025 at 4:31 PM
Reposted by Dr Theodora Katsila
helloeacr.bsky.social
Join us this November in Bergamo to help shape the future of early-onset cancer research!

We're excited to bring you this brand new conference topic, exploring the biology, causes and detection of cancer in younger patients.

In partnership with @themarkfdn.bsky.social 💙

eacr.org/conference/m...
March 12, 2025 at 2:49 PM
Reposted by Dr Theodora Katsila
helloeacr.bsky.social
Submissions are open for the EACR - @themarkfdn.bsky.social Postdoctoral Fellowships until 20 August!

This funding is awarded for a period of three years to support excellent postdoctoral researchers in laboratories throughout Europe 🌍

Learn more: eacr.org/eacr-fellows...
August 6, 2025 at 8:02 AM
theodorakatsila.bsky.social
The @katsilalab.bsky.social is joining the Network for Cardiovascular Pharmacogenomics and Precision Medicine!! Looking forward to sharing our progress and connecting with fellow researchers, clinicians, and decision-makers across Europe. www.cost.eu/actions/CA24...
#CardioPharmaGENET #COST
Network for Cardiovascular Pharmacogenomics and Precision Medicine
CardioPharmaGENET aims to advance personalized medicine in cardiovascular care by leveraging pharmacogenomics (PGx) to optimize drug therapies. In cardiovascular medicine, this approach is especially ...
www.cost.eu
July 24, 2025 at 12:54 PM
theodorakatsila.bsky.social
Grateful to @Sci2Business & @OrangeGroveGr for the #TechTransferAtelier journey!! Our #IN3 system - my vision to bridge expertise with planetary health impact. Refined IP & commercialization pathways. Next steps ahead!! #IPStrategy #ResearchCommercialization @katsilalab.bsky.social
July 8, 2025 at 10:32 PM
theodorakatsila.bsky.social
Join Cancer Neuroscience in Bilbao, Spain (14-16 Oct 2025) for the opportunity to discover a detailed overview of the most recent advances in the field of cancer neuroscience: www.eacr.org/conference/cancerneuroscience2025 #CancerResearch #Oncology @helloeacr.bsky.social
Introduction | Cancer Neuroscience | The European Association for Cancer Research
www.eacr.org
May 30, 2025 at 4:19 PM
theodorakatsila.bsky.social
mic drop :)
Mass Spec
xkcd.com
May 27, 2025 at 7:38 AM
Reposted by Dr Theodora Katsila
cashwood.proteaglyco.com
Disappointing to see, across both parties.
Sciex is no longer providing funding for Skyline/Proteowizard as part of the multi-vendor agreement to keep Skyline supported across all major vendors.
I can see the arguments from both sides, just a shame it's resulted in this.
Transcribed text: Skyline Targeted Mass Spec Environment Dear Skyline Users, I would like to thank Agilent, Bruker, Shimadzu, Thermo Fisher, and Waters for their continued funding support for the Skyline project this year. This industry/government/university partnership allows all of us to maximize the value of our efforts to provide better mass spectrometry tools to the field. In the current federal funding environment, industry support is critical to maintain our work. Some instrument vendors, such as SCIEX, have not invested in the Skyline project this year. As a public university, we are limited in how we can support the private sector under state law. We paused our work in Skyline and ProteoWizard on support for SCIEX instruments to remain in compliance with state law. While we hoped SCIEX would resume its funding support of the Skyline project for use with their instruments, and respect their decision not to provide funding, we cannot continue our work to support SCIEX in Skyline or ProteoWizard without SCIEX funding. We have informed the ProteoWizard Foundation of this development. As always, we look forward to seeing many of you at ASMS or our Skyline course at UW this summer. We thank all of you for your continued support. Brendan MacLean, Skyline Project Lead
May 13, 2025 at 1:34 PM
theodorakatsila.bsky.social
🚨 We’re kicking off #MALDIBANK – to create a global, open MALDI spectra databank for faster, smarter microbial ID!! 🌍🔬
📍 May 13–15, 2025 | Braga, Portugal
🧠 Coordinated by @MIRRI_ERIC
🔗 #Microbiology #OpenScience #MALDIToF #EUresearch #Biotech #Metabolomics #HorizonEurope #MALDIBANK2025
May 13, 2025 at 10:35 AM
theodorakatsila.bsky.social
🚀🚀 Excited to kick off #ENVESOME, a 4-year #HorizonEurope project tackling how urban environmental exposures affect human health www.linkedin.com/feed/update/... @katsilalab.bsky.social #UrbanHealth #Exposome #EnvironmentalHealth #ClimateHealth #PublicHealth #ScienceForPolicy #HorizonEU #ENVESOME
#envesome #horizoneurope #urbanhealth #exposome #environmentalhealth… | Dr. Theodora Katsila
🚀 Excited to kick off #ENVESOME, a 4-year #HorizonEurope project tackling how urban environmental exposures affect human health. Led by NHRF and involving 16 partners across 8 countries, we’re thrill...
www.linkedin.com
May 5, 2025 at 5:58 PM
theodorakatsila.bsky.social
Big news! 🎉 Our consortium just won a new #MSCA Doctoral Network (ITN): ACHILLES 🔬💥 We’ll train future leaders in experimental #hematooncology & use #AI-aided #drug #repurposing for blood cancers.
@katsilalab.bsky.social @EIEgr @belverlab @carrerasijc.bsky.social 🧠🚀
#HorizonEU #PhDpositions
April 17, 2025 at 6:16 PM
theodorakatsila.bsky.social
What a ride the past few days!
Had the honor of joining #Beyond2025 with 15K+ innovators 🧠🌍 In the @GSRT_GR @EIEgr session “Beyond Intelligence”, I shared our @katsilalab.bsky.social work on AI-driven drug repurposing 🌐🤖🧪💊📈

#AI #DrugDiscovery
April 17, 2025 at 6:11 PM